Shares of Validus Holdings, Ltd. (NYSE:VR) have been assigned an average recommendation of “Hold” from the eleven ratings firms that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $54.83.
A number of research analysts have weighed in on the stock. UBS lifted their price target on shares of Validus from $48.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Bank of America raised shares of Validus from a “neutral” rating to a “buy” rating in a research note on Monday, October 30th. ValuEngine raised shares of Validus from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. Barclays cut their price target on shares of Validus from $57.00 to $53.00 and set an “equal weight” rating on the stock in a research note on Monday, October 16th. Finally, TheStreet lowered shares of Validus from a “b” rating to a “c+” rating in a research report on Wednesday, October 11th.
In other Validus news, CEO Lixin Zeng sold 26,136 shares of the company’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $52.10, for a total transaction of $1,361,685.60. Following the sale, the chief executive officer now directly owns 57,855 shares of the company’s stock, valued at $3,014,245.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Kean Driscoll sold 6,875 shares of the company’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $50.30, for a total transaction of $345,812.50. The disclosure for this sale can be found here. Insiders own 2.33% of the company’s stock.
Shares of Validus (VR) traded up $0.69 on Thursday, reaching $46.85. 1,090,000 shares of the company’s stock were exchanged, compared to its average volume of 682,819. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.95 and a current ratio of 0.95. Validus has a 1 year low of $41.15 and a 1 year high of $58.76.
Validus (NYSE:VR) last announced its quarterly earnings results on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($3.30) by $0.08. Validus had a negative net margin of 1.38% and a negative return on equity of 0.49%. The firm had revenue of $407.00 million for the quarter, compared to analyst estimates of $453.04 million. During the same quarter in the previous year, the firm posted $1.02 earnings per share. The business’s revenue was up 24.3% on a year-over-year basis. analysts anticipate that Validus will post -0.24 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 15th will be given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.24%. The ex-dividend date of this dividend is Thursday, December 14th. Validus’s dividend payout ratio is presently -233.84%.
Validus Company Profile
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.